METROPOLITAN LIFE INSURANCE CO/NY – Regeneron Pharmaceuticals, Inc. Transaction History
METROPOLITAN LIFE INSURANCE CO/NY portfolio value:
$4.24M
portfolio value
METROPOLITAN LIFE INSURANCE CO/NY quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.99% | -125 shares | 528K | $688.87 | 6.15K |
Q2 2022 | share | Decrease | -1.27% | -81 shares | -731K | $591.13 | 6.28K |
Q1 2022 | share | Decrease | -48.10% | -5.89K shares | -3.29M | $698.42 | 6.36K |
Q4 2021 | share | Increase | +13.89% | 1.49K shares | 1.22M | $642.51 | 12.25K |
Q3 2021 | share | Decrease | -17.03% | -2.20K shares | -732K | $605.18 | 10.76K |
Q2 2021 | share | Increase | +71961.11% | 12.95K shares | 7.23M | $558.54 | 12.97K |
Q1 2021 | share | Decrease | -99.90% | -18.62K shares | -8.99M | $473.14 | 18 |
Q4 2020 | share | Decrease | -4.21% | -819 shares | -1.88M | $483.11 | 18.64K |
Q3 2020 | share | Decrease | -1.79% | -354 shares | -1.46M | $559.78 | 19.46K |
Q2 2020 | share | Increase | +55.34% | 7.05K shares | 6.12M | $623.65 | 19.81K |
Q1 2020 | share | Decrease | -0.65% | -83 shares | 1.40M | $488.29 | 12.75K |
Q4 2019 | share | Decrease | -0.12% | -16 shares | 1.25M | $375.48 | 12.83K |
Q3 2019 | share | Decrease | -18.64% | -2.94K shares | -1.37M | $277.4 | 12.85K |
Q2 2019 | share | Increase | +4.96% | 746 shares | -1.23M | $313 | 15.79K |
Q1 2019 | share | Decrease | -2.14% | -329 shares | 436K | $410.62 | 15.05K |
Q4 2018 | share | Increase | +0.23% | 35 shares | -456K | $373.5 | 15.38K |
Q3 2018 | share | Decrease | -2.15% | -338 shares | 789.83K | $404.04 | 15.34K |
Q2 2018 | share | Increase | +1.14% | 177 shares | 70.83K | $344.99 | 15.68K |
Q1 2018 | share | Increase | +0.60% | 93 shares | -454.66K | $344.36 | 15.50K |
Q4 2017 | share | Decrease | -61.32% | -24.43K shares | -12.02M | $375.96 | 15.41K |
Q3 2017 | share | Decrease | -0.54% | -216 shares | -1.86M | $447.12 | 39.85K |
Q2 2017 | share | Decrease | -1.34% | -544 shares | 3.94M | $491.14 | 40.06K |
Q1 2017 | share | Decrease | -0.85% | -348 shares | 702K | $387.51 | 40.61K |
Q4 2016 | share | Decrease | -2.58% | -1.08K shares | -1.86M | $367.09 | 40.96K |
Q3 2016 | share | Decrease | -4.02% | -1.76K shares | 1.60M | $402.02 | 42.04K |
Q2 2016 | share | Decrease | -1.14% | -507 shares | -674K | $349.23 | 43.80K |
Q1 2016 | share | Decrease | -0.84% | -375 shares | -8.28M | $360.44 | 44.31K |